This site uses cookies to offer you a better browsing experience.
Learn more
Pharmaceuticals Bayer: Science For A Better Life

You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it.

Find us in your country
Find us in your country

Latest press releases

Partnering

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Bayer Receives FDA Approval for Second-Line Systemic Treatment of Liver Cancer

Chagas Disease

Click here to learn more about Chagas and how we’re helping to fight it.
Healthy aging

Healthy aging

Bayer at ISTH 2017

Bayer at ISTH 2017

Information about Bayer sponsored clinical studies

Bayer Trial Finder

Clinicaltrials.gov

Data Sharing Portal

News

2017-07-21

Phase II Trial of Investigational Anetumab Ravtansine Does Not Meet Primary Endpoint in Second-Line Mesothelioma

2017-07-21

Bayer’s Xarelto in Combination with Single Antiplatelet Therapy Receives Positive CHMP Opinion for Treatment of Patients with Atrial Fibrillation requiring oral Anticoagulation and undergoing Percutaneous Coronary Intervention with Stent Placement

2017-07-03

New Data from Bayer’s Portfolio in Thrombosis and Hemophilia to be Presented at ISTH 2017

2017-07-03

Bayer starts Phase III study program with Vilaprisan in the treatment of symptomatic uterine fibroids

2017-06-26

Bayer Receives Approval for Stivarga® in Japan for Second-Line Treatment of Hepatocellular Carcinoma
Press center